284 related articles for article (PubMed ID: 3518963)
21. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Baumgärtner M; Grehn M; Wundt W
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
[TBL] [Abstract][Full Text] [Related]
22. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
23. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Verbist L
Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
[TBL] [Abstract][Full Text] [Related]
24. [The antibacterial activity of cefmetazole and other antibiotics to 463 isolates].
Xu Y; Wang H; Chen M
Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):540-2. PubMed ID: 10436961
[TBL] [Abstract][Full Text] [Related]
25. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
Rouhan D; Le Noc P; Le Noc D
Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
[TBL] [Abstract][Full Text] [Related]
26. Comparative activity of ceftizoxime against aminoglycoside-resistant aerobic gram-negative bacilli.
Gómez-Lus R; Rubio MC; García C; Gómez-Lus ML; Alejandre MC
Drugs Exp Clin Res; 1987; 13(3):155-9. PubMed ID: 3497792
[TBL] [Abstract][Full Text] [Related]
27. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
Aldridge KE
Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
[TBL] [Abstract][Full Text] [Related]
28. [Susceptibility of some bacteria isolated from clinical samples to third-generation cephalosporins].
Willke A; Tural D
Mikrobiyol Bul; 1987 Oct; 21(4):279-83. PubMed ID: 3332704
[TBL] [Abstract][Full Text] [Related]
29. Antibacterial activity of cefamandole in vitro.
Meyers BR; Hirschman SZ
J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
Matsuo K; Uete T
Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
George WL; Lewis RP; Meyer RD
Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
[TBL] [Abstract][Full Text] [Related]
32. Susceptibilities of gentamicin-resistant Gram-negative aerobic bacilli to cefotetan and other beta-lactams.
Hart CA; Percival A
J Antimicrob Chemother; 1983 Jan; 11 Suppl():95-101. PubMed ID: 6573329
[TBL] [Abstract][Full Text] [Related]
33. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
Braveny I; Dickert H; Machka K
Infection; 1979; 7(5):231-6. PubMed ID: 389804
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial activity of cefmetazole compared with those of other cephalosporins.
Schell RF; Kurzynski TA; Le Frock JL; Donato JB
Chemotherapy; 1986; 32(5):431-8. PubMed ID: 3463448
[TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
36. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
Thabaut A; Durosoir JL; Saliou P
Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
[TBL] [Abstract][Full Text] [Related]
37. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
[TBL] [Abstract][Full Text] [Related]
38. [The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's transl)].
Schröter G; Loch R
Zentralbl Bakteriol Orig A; 1979; 245(3):317-23. PubMed ID: 44786
[TBL] [Abstract][Full Text] [Related]
39. Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
Barry AL; Gavan TL; Jones RN; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
Diagn Microbiol Infect Dis; 1987 May; 7(1):83-7. PubMed ID: 3121242
[TBL] [Abstract][Full Text] [Related]
40. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Thabaut A; Durosoir JL; Saliou P
Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
